Literature DB >> 11052953

Determinants of glucose toxicity and its reversibility in the pancreatic islet beta-cell line, HIT-T15.

C E Gleason1, M Gonzalez, J S Harmon, R P Robertson.   

Abstract

HIT-T15 cells, a clonal beta-cell line, were cultured and passaged weekly for 6 mo in RPMI 1640 media containing various concentrations of glucose. Insulin content decreased in the intermediate- and late-passage cells as a continuous rather than a threshold glucose concentration effect. In a second series of experiments, cells were grown in media containing either 0.8 or 16.0 mM glucose from passages 76 through 105. Subcultures of passages 86, 92, and 99 that had been grown in media containing 16.0 mM glucose were switched to media containing 0.8 mM glucose and also carried forward to passage 105. Dramatic increases in insulin content and secretion and insulin gene expression were observed when the switches were made at passages 86 and 92 but not when the switch was made at passage 99. These findings suggest that glucose toxicity of insulin-secreting cells is a continuous rather than a threshold function of glucose concentration and that the shorter the period of antecedent glucose toxicity, the more likely that full recovery of cell function will occur.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11052953     DOI: 10.1152/ajpendo.2000.279.5.E997

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  28 in total

1.  Determination of Optimal Sample Size for Quantification of β-Cell Area, Amyloid Area and β-Cell Apoptosis in Isolated Islets.

Authors:  Daniel T Meier; Leon Entrup; Andrew T Templin; Meghan F Hogan; Thanya Samarasekera; Sakeneh Zraika; Edward J Boyko; Steven E Kahn
Journal:  J Histochem Cytochem       Date:  2015-08       Impact factor: 2.479

Review 2.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

3.  Genetics of new-onset diabetes after transplantation.

Authors:  Jennifer A McCaughan; Amy Jayne McKnight; Alexander P Maxwell
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

4.  Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes.

Authors:  Defeng Wang; Li Sun; Guangyao Song; Shuchun Chen
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Nrf2/antioxidant pathway mediates β cell self-repair after damage by high-fat diet-induced oxidative stress.

Authors:  Tsehay Abebe; Jana Mahadevan; Lindsey Bogachus; Stephanie Hahn; Michele Black; Elizabeth Oseid; Fumihiko Urano; Vincenzo Cirulli; R Paul Robertson
Journal:  JCI Insight       Date:  2017-12-21

6.  Effects of short-term intensive glycemic control on insulin, glucagon, and glucagon-like peptide-1 secretion in patients with Type 2 diabetes.

Authors:  M Shimodaira; Y Muroya; N Kumagai; K Tsuzawa; K Honda
Journal:  J Endocrinol Invest       Date:  2013-04-12       Impact factor: 4.256

7.  Bottom-up proteomics analysis of the secretome of murine islets of Langerhans in elevated glucose levels.

Authors:  Andrew Schmudlach; Jeremy Felton; Robert T Kennedy; Norman J Dovichi
Journal:  Analyst       Date:  2017-01-16       Impact factor: 4.616

8.  The effect of early insulin therapy on pancreatic β-cell function and long-term glycemic control in newly diagnosed type 2 diabetic patients.

Authors:  Suk Chon; Seungjoon Oh; Sung Woon Kim; Jin-Woo Kim; Young Seol Kim; Jeong-taek Woo
Journal:  Korean J Intern Med       Date:  2010-08-31       Impact factor: 3.165

Review 9.  Interventions to preserve beta-cell function in the management and prevention of type 2 diabetes.

Authors:  Kathleen A Page; Tamar Reisman
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

Review 10.  Early insulin treatment in type 2 diabetes: what are the pros?

Authors:  Luigi F Meneghini
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.